Defibrillators Market is Expected to Exceed USD 15.75 Billion by 2020 Defibrillators Market 2020

Defibrillators Market Is Expected to Exceed USD 15.75 billion by
2020: Radiant Insights, Inc
Global defibrillator market is expected to reach USD 15.75 billion by 2020. Defibrillators, owing to their
capability to resolve cardiac related conditions such as cardiac arrhythmias, ventricular tachycardia and
ventricular fibrillation are expected to witness substantial growth over the forecast period. Increasing
incidences of cardiovascular diseases and rising geriatric population base are some key factors expected
to drive market growth by widening the patient base. Moreover, improving healthcare infrastructure and
growing focus of key market players on emerging economies is also expected to fuel the growth of this
market. Defibrillators are most commonly used to deliver therapeutic doses of electrical energy to the
heart in case of a cardiac arrhythmia. Rising mortality rates associated with sudden cardiac arrest (SCA)
has led to a consequential rise in demand for defibrillators.
Further key findings from the study suggest:
Implantable cardioverter defibrillator (ICD) is the most lucrative product segment. The global market for
ICD is expected to grow at a rate of over 6.0% over the forecast period owing to their ability to avoid
sudden cardiac arrest (SCA).
Browse Full Report With TOC @ http://www.radiantinsights.com/research/defibrillators-marketanalysis-by-product-implantable-cardioverter-defibrillator-external-defibrillator-by-end-usehospital-pre-hospital-public-access-market-alternate-care-market-homes-and-segment-forecasts-to2020
The product is also expected to remain as the most revenue generating segment of the market throughout
the forecast period. The rise in demand for single and dual chamber ICDs are some factors expected to
drive segment growth over the next six years.
North America accounted for more than 35.0% of the defibrillator market in 2013. High adoption rates of
technologically advanced products and the presence of a sophisticated healthcare infrastructure in the
region are some key factors expected to drive regional market growth. Moreover, growing geriatric
population base and the prevalence of disease inducing lifestyle habits are expected to widen the patient
base, thereby, providing manufacturers with future growth opportunities.
Asia Pacific is identified as the most lucrative region of the market. Presence of high unmet needs in the
emerging markets of China and India and growing patient awareness levels are some factors expected to
drive market growth over the forecast period.
Key players of this market include St. Jude Medical Inc, Boston Scientific Corporation, Biotronik SE &
Co. KG, Sorin Group, ZOLL Medical Corporation, HeartSine Technologies, Nihon Kohden Corporation,
Defibtech LLC, GE Healthcare, Welch Allyn, Koninklijke Philips N.V., Cardiac Science Corporation and
Physio Control Inc.